Huma Secures EU MDR Approval For Medtech Software That Can Be Used In Any Disease

 
• By Eliza Slawther

Huma Therapeutics has secured the first ever EU regulatory approval for a “disease agnostic” class IIb medtech software platform. CEO Dan Vahdat tells Medtech Insight how the product can be configured to monitor patients with any condition.

Huma Therapeutics
• Source: Huma Therapeutics

More from Europe

More from Geography